Topical menthol back patch recalled for manufacturing deviations
ABSORBINE jr. Extra Large Back Patch containing 5% menthol is being recalled nationwide due to manufacturing compliance deviations. The Class II recall affects 6,848,820 patches distributed by Absorbine Jr., LLC.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for manufacturing process deviations with no reported illnesses or injuries. The recall was voluntary and precautionary in nature. Voluntary precautionary recalls without reported health effects align with Moderate severity per the rubric.
Plain-English summary
ABSORBINE jr. Extra Large Back Patch is a topical menthol patch containing 5% menthol, manufactured by Unexo Life Sciences Private Limited and distributed by Absorbine Jr., LLC. The recalled product consists of 6,848,820 patches with UPC codes 8 89476 41218 6 and 8 89476 41236 0.
The FDA issued a Class II recall on December 4, 2024, for cGMP deviations at the manufacturing facility. The manufacturer voluntarily initiated the recall on October 24, 2024, and the recall was terminated on September 16, 2025.
The recalled patches were distributed nationwide in the United States. Consumers who have this product should discontinue use.
The recalled product
- Product
- ABSORBINE jr. Extra Large BACK PATCH, Menthol 5%, 1 extra large patch per box, Distributed By: Absorbine Jr., LLC, Chattanooga, TN 37402 UPC 8 89476 41218 6, UPC 8 89476 41236 0
- Manufacturer
- Unexo Life Sciences Private Limited
- Category
- Drug — Topical patch
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UPC 8 89476 41218 6
- UPC 8 89476 41236 0
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27